Blumberg Institute is an esteemed brand in the field of biomedical research. Established in 2003 by the Hepatitis B Foundation, it stands as an independent nonprofit research institute dedicated to advancing its research mission. With a primary focus on hepatitis B and liver cancer, Blumberg Institute is at the forefront of translational research.

The institute supports various research programs, including drug discovery, biomarker discovery, and translational biotechnology, all centered around chronic hepatitis, liver disease, and liver cancer. It fosters an environment that encourages collaboration, interaction, and innovation. Driven by its mission, Blumberg Institute utilizes discovery science to identify breakthrough therapies and biomarkers for hepatitis B and liver cancer.

In addition to traditional scholarship and educational opportunities, the institute also engages in public health outreach programs, aiming to enhance the quality of life for individuals affected by chronic hepatitis B worldwide. Join Blumberg Institute in their pursuit of groundbreaking research and help contribute to a world free from the burdens of hepatitis B and liver cancer